期刊文献+

阿司匹林抵抗研究存在的问题与展望

A Study of Aspirin Resistance
下载PDF
导出
摘要 阿司匹林是心血管疾病治疗的关键用药之一。虽然它能有效的抗血小板聚集,但是有些患者经过长期随访仍有心血管事件发生,称为阿司匹林抵抗。阿司匹林抵抗的机制不明确,而且缺乏快速的、临床实用的、准确的检测方法。通过进一步研究阿司匹林抵抗的机制和临床特征,我们应该象监测胆固醇、血压、血糖一样,监测血小板活性而指导患者进行个体化的抗血小板治疗,从而提高此类患者的治疗效果。 Aspirin has emerged as an important element of the treatment of cardiovascular disease. Despite its efficacy, patients on these medications continue to suffer complications. Aspirin resistance is an emerging clinical entity with potentially severe consequences. The mechanism of resistance remains incompletely defined. Rapid and accurate diagnosis of antiplatelet resistance also remains an issue as new bedside tests are developed. By understanding the mechanism of therapeutic failure and by improving the diagnosis of this clinical entity, a new era of individualized antiplatelet therapy may come about, with routine measurements of platelet activity, in the same way that cholester- ol, blood pressure, and blood sugar are monitored, thus improving care for millions of people.
出处 《心血管病学进展》 CAS 2006年第6期741-743,共3页 Advances in Cardiovascular Diseases
关键词 阿司匹林抵抗 问题 展望 心血管疾病 aspirin resistance stumble prospect
  • 相关文献

参考文献26

  • 1Metha J,Metha P,Burger C,et al.Platelet aggregation studies in coronary artery disease[J].Atherosclerosis,1978,31:169-175.
  • 2Patrono C,Coller B,Dalen JE,et al.Platelet active drugs:the relationships among dose,effectiveness,and side effects[J].Chest,2001,119(1s):39-63.
  • 3Rocca B,Patrono C.Determinants of the interindividual variability in response to antiplatelet drugs[J].J Thromb Haemost,2005,3(8):1597-1602.
  • 4Hobikoglu GF,Norgaz T,Aksu H,et al.High frequency of aspirin resistance in patients with acute coronary syndrome[J].Tohoku J Exp Med,2005,207(1):59-64.
  • 5Sanderson S,Emery J,Baglin T,et al.Narrative review:Aspirin resistance and its clinical implications[J].Ann Intern Med,2005,142:370-380.
  • 6Matzdorff A.Platelet function tests and flow cytometry to monitor antiplatelet therapy[J].Semin Thromb Hemost,2005,31(4):393-399.
  • 7阮长耿,王山喜,毛静安,张晓林,陈惠娟,王东.体内、外血小板活化时血浆11-去氢-血栓烷B2的改变及其意义[J].中国病理生理杂志,1998,14(2):149-152. 被引量:8
  • 8王山岭,王丽霞,孙月和.不同时间服用阿司匹林对老年原发性高血压患者血小板功能及血压的影响[J].中国综合临床,2005,21(2):101-102. 被引量:4
  • 9Lee PY,Chen WH,Ng W,et al.Low-dose aspirin increases aspirin resistance in patients with coronary artery disease[J].Am J Med,2005,118(7):723-727.
  • 10Hanjis C,Frishman WH,Lerner RG.Aspirin resistance:mechanisms and clinical implications[J].Cardiol Rev,2006,14(1):18-25.

二级参考文献76

  • 1段卫,黄叔怀.运动诱导的血小板活化机制研究进展[J].浙江体育科学,2000,22(6):38-41. 被引量:4
  • 2[1]Anonymous. Collaborative overview of randomised trials of antiplatelet therapy Ⅰ~Ⅲ . BMJ, 1994, 308(6921-6923): 81-106, 159-168,235 -246.
  • 3[2]Patrono C, Coller B, Dalen JE, et al. Platelet-active drugs. the relationships among dose, effectiveness, and side effect. Chest, 2001, 119(Suppl1): 39S-63S.
  • 4[3]Helgason CM, Bolin KM, Hoff JA, et al. Development of aspirin resistance in persons with previous ischemic stroke. Stroke, 1994, 25(12):2331-2336.
  • 5[4]Papps JM, Westengard JC, Bull BS. Population variability in the effect of aspirin on platelet function. implications for clinical trials and therapy.Arch Patrol Lab Med, 1994, 118(8): 801-804.
  • 6[5]Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspiprin non-responder. a pilot-study including 180 post-stroke patients. Thromb Res, 1993, 71 (5): 397-403.
  • 7[6]Weber AA, Przytulski B, Schanz A, et al. Towards a definition of aspirin resistance: a typological approach. Platelets, 2002, 13 ( 1 ): 37-40.
  • 8[7]Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cycloxygenase) isozymes by aspirin and other nonsteroidal anti-inflammatory drugs. J Biol Chem, 1993, 268(9): 6610-6614.
  • 9[8]Karim S, Habib A, Levy-Toledano S, et al. Cycloxygenase-1 and-2 of endothe lial cells utilize exogenous or endogenous arachidonic acid for transcelluar production of thromboxane. J Biol Chem, 1996, 271(20):12042-12048.
  • 10[9]Vane JR, Bakhle YS, Botting RM. Cycloxygenase 1 and 2. Annu Rev Pharmacol Toxicol, 1998, 38: 97-120.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部